Question Everything. See who's reporting it.

FDA revokes drug licence over packaging issues, court orders review

Source: The Hindu

The story in brief

The Bombay High Court criticized the FDA for revoking Cipla’s drug licence without a hearing, citing procedural flaws. The FDA cited packaging and record issues but issued the order on a public holiday. The court questioned the FDA’s expectation of a response on a holiday, noting the government often seeks adjournments for such days. The FDA agreed to withdraw the revocation and issue a fresh notice. This was not the first time the FDA acted similarly.

NEWXFree on Android and iPhone. Open in NEWX